Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03145064
Brief Title: Study of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma

First Submitted : May 5, 2017
First Submitted that Met QC Criteria : May 5, 2017
First Posted : May 9, 2017

Last Update Submitted that Met QC Criteria : November 5, 2020
Last Update Posted : November 9, 2020